Showing 780 – 790 of 1304 results
-
Things Are Improving for Lower Income Consumers
In this Economics Weekly we take a look at the consumer, what’s happened with regard to the wealth inequality gap, and why some of the more recent economic data actually sheds a ray of hope that solid progress is being made in addressing this issue.
-
SPH Analytics and Press Ganey Transaction
William Blair acted as exclusive financial advisor to SPH Analytics, a portfolio company of Symphony Technology Group, in connection with its sale to Press Ganey.
-
People Corporation and Goldman Sachs Merchant Banking
William Blair acted as the financial advisor to People Corporation (TSX Venture: PEO) in connection with its pending take-private sale to Goldman Sachs Merchant Banking.
-
William Blair Names 24 New Partners
William Blair the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today it named 24 new partners worldwide this month.
-
Trans Teens Captivate Latest Courageous Conversations
Champions of GenderCool, a national campaign that spotlights the remarkable stories of transgender youth, captured the hearts and minds of colleagues attending the latest William Blair Courageous Conversations.
-
Will the Fed End Its QT in 2024
Richard de Chazal examines another important aspect of the Fed—its balance sheet—and outlines what has motivated the discussion on ending its quantitative tightening (QT) so soon.
-
Lindblad Expeditions Holdings Inc Initiation
William Blair initiated research coverage of Lindblad Expeditions Holdings, Inc. (LIND $16.11), which provides expedition cruising and adventure travel experiences. The company’s land- and sea-based itineraries are crafted for travelers seeking premium, immersive, and up-close encounters with wildlife, nature, history, and culture.
-
Sight Sciences Inc Initiation
William Blair initiated research coverage of Sight Sciences, Inc. (SGHT $14.62).
-
Enovis Corporation: Initiation of Research Coverage
William Blair initiated research coverage of Enovis Corporation (ENOV $56.02), a medical device company focused on products spanning the orthopedic care spectrum.
-
Cancer Immunotherapy Conference
The William Blair Biotechnology Team co-hosted the ninth annual Cancer Immunotherapy Conference on March 20 and 21 in New York. This conference showcases the scientists and clinicians driving the advancements in the field of cancer immunotherapy and is designed to facilitate discussion with the audience to further elucidate underlying mechanisms of biology and promising novel therapies.